InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
7
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-12.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Seizinger Bernd R., Director. Insider active across 3 companies, notably Aprea Therapeutics, Inc.. Cumulatively, 14 filings have been recorded. Split: 7 buys · 0 sell. Total volume traded: €299k. Activity tracked since 30 June 2021. The latest transaction was filed on 11 February 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Seizinger Bernd R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
17,000 sharesCommon SharesSEC:0000912282-26-000902:0
3,135 sharesCommon StockSEC:0001104659-26-075278:0
60,000 shares@ US$0.826531.8% of flowCommon SharesSEC:0001493152-26-006548:0
Canonical exit: 12 May 2026 (T+90)
100,000 shares@ US$1.037768.2% of flowCommon SharesSEC:0001493152-26-002879:0
Canonical exit: 16 Apr 2026 (T+90)
1,045 shares0Common StockSEC:0001104659-25-057823:0
10,000 shares@ US$2.6820.8% of flowCommon StockSEC:0001104659-24-108377:0
Canonical exit: 9 Jan 2025 (T+90)
1,045 shares0Common StockSEC:0001104659-24-073950:0
6,860 shares@ US$7.2938.8% of flowCommon StockSEC:0001104659-24-034672:0
Canonical exit: 11 Jun 2024 (T+90)
17,000 shares@ US$3.14100.0% of flowCommon SharesSEC:0000912282-23-000385:0
Canonical exit: 21 Dec 2023 (T+90)
500 shares0Common StockSEC:0001104659-23-095016:0
4,068 shares@ US$3.629411.7% of flowCommon StockSEC:0001104659-23-069421:0
Canonical exit: 4 Sept 2023 (T+90)
5,995 shares0Common StockSEC:0001104659-22-084775:0
50,000 shares@ US$0.7128.7% of flowCommon StockSEC:0001104659-22-062920:0
Canonical exit: 16 Aug 2022 (T+90)
4,610 shares0Common StockSEC:0001567619-21-012872:0
14 of 14 declarations
About Seizinger Bernd R.
Bernd R. Seizinger is an Administrateur of Aprea Therapeutics, Inc. and ONCOLYTICS BIOTECH INC, and is linked to Aptose Biosciences Inc. There are 14 filings in total, all acquisitions. Across the 14 sampled recent filings, purchases total 299137 EUR, with no sales, between 2021-07-01 and 2026-07-02. The main filings concern ONCOLYTICS BIOTECH INC, Aptose Biosciences Inc., and Aprea Therapeutics, Inc.
